Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: Athlone Pharmaceuticals Limited, Connaught House, 1 Burlington Road, Dublin 4, D04 C5Y6, Ireland
Trimoptin Tablets 100 mg.
| Pharmaceutical Form |
|---|
|
Tablet. Flat, white, bevelled-edge tablets embossed ‘TR 100’. |
Each tablet contains Trimethoprim 100 mg.
Also contains 10mg lactose monohydrate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Trimethoprim |
Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Polypropylene tablet container of 15, 18, 20, 21, 28, 30, 100 or 500 tablets with a high-density/low-density polyethylene blend cap and low-density polyethylene snap filler. Also available in a PVC blister with aluminum lidding foil containing 28 tablets.
Not all pack sizes may be marketed.
Athlone Pharmaceuticals Limited, Connaught House, 1 Burlington Road, Dublin 4, D04 C5Y6, Ireland
PA1418/008/001
Date of first authorisation: 30 July 2004
Date of last renewal: 30 July 2009
| Drug | Countries | |
|---|---|---|
| TRIMOPTIN | Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
